Pharmacist-Led Program Brings Pre-Exposure Prophylaxis Monoclonal Antibodies to Patients At High Risk of Contracting COVID-19

In an interview with Pharmacy Times, Alfred L'Altrelli, PharmD, senior director of pharmacy at UPMC Presbyterian-Shadyside, discussed the health system's new program offering monoclonal antibodies as pre-exposure prophylaxis for patients who are immunocompromised or who did not respond adequately to COVID-19 vaccination.

In the interview, L'Altrelli said having such a program spearheaded by pharmacists has helped show the public the vital roles that pharmacists play. He added that pharmacists are perfectly positioned to lead the program, considering their expertise with vaccinations and managing limited supplies. Furthermore, L'Altrelli said they have had overwhelming support from patients, who are excited to regain a feeling of safety after nearly 2 years of isolation.

Patient George P. Spine, Jr, said he was hesitant when he first received a phone call offering the treatment, but after talking to his son he decided to get the 2-shot series. At 87 years old, Spine said he hopes to live to see 88.

All footage and images courtesy of UPMC Presbyterian-Shadyside.